Literature DB >> 7769691

Effect of single-base substitutions in the central domain of virus-associated RNA I on its function.

A Rahman1, P Malhotra, R Dhar, T Kewalramani, B Thimmapaya.   

Abstract

Adenoviruses use virus-associated RNA I (VAI RNA) to counteract the cellular antiviral response mediated by the interferon-induced, double-stranded-RNA-activated protein kinase PKR. VAI RNA is a highly structured small RNA which consists of two long duplex regions connected at the center by a complex, short stem-loop. This short stem-loop and the adjacent base-paired regions, referred to as the central domain, bind to PKR and inactivate it. Currently it is not known whether binding of VAI RNA to PKR is dependent solely on the secondary (and tertiary) structure of the central domain or whether nucleotide sequences in the central domain are also critical for this interaction. To address this question, 54 VAI mutants with single-base substitution mutations in the central domain of the RNA were constructed, and their capacities to inhibit the autophosphoryation of PKR in vitro were determined. It was found that although about half of the mutants inhibited PKR activity as efficiently as the wild type, a significant number of mutants lost the inhibitory activity substantially, without a perceptible change in their secondary structures. These results indicate that, in addition to secondary structure, at least some nucleotides in the central domain may be critical for the efficient function of VAI RNA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7769691      PMCID: PMC189169          DOI: 10.1128/JVI.69.7.4299-4307.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Interaction of adenovirus VA RNAl with the protein kinase DAI: nonequivalence of binding and function.

Authors:  K H Mellits; M Kostura; M B Mathews
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

Review 2.  The double stranded RNA-activated protein kinase induced by interferon: dsRNA-PK.

Authors:  A G Hovanessian
Journal:  J Interferon Res       Date:  1989-12

3.  Functional dissection of adenovirus VAI RNA.

Authors:  M R Furtado; S Subramanian; R A Bhat; D M Fowlkes; B Safer; B Thimmappaya
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

4.  Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase.

Authors:  J Kitajewski; R J Schneider; B Safer; S M Munemitsu; C E Samuel; B Thimmappaya; T Shenk
Journal:  Cell       Date:  1986-04-25       Impact factor: 41.582

5.  A mechanism for the control of protein synthesis by adenovirus VA RNAI.

Authors:  R P O'Malley; T M Mariano; J Siekierka; M B Mathews
Journal:  Cell       Date:  1986-02-14       Impact factor: 41.582

Review 6.  Impact of virus infection on host cell protein synthesis.

Authors:  R J Schneider; T Shenk
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

7.  Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded-RNA-activated protein kinase.

Authors:  S Gunnery; A P Rice; H D Robertson; M B Mathews
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

8.  Construction and analysis of additional adenovirus substitution mutants confirm the complementation of VAI RNA function by two small RNAs encoded by Epstein-Barr virus.

Authors:  R A Bhat; B Thimmappaya
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

9.  Effects of mutations in stem and loop regions on the structure and function of adenovirus VA RNAI.

Authors:  K H Mellits; M B Mathews
Journal:  EMBO J       Date:  1988-09       Impact factor: 11.598

10.  Adenovirus VAI RNA complexes with the 68 000 Mr protein kinase to regulate its autophosphorylation and activity.

Authors:  M G Katze; D DeCorato; B Safer; J Galabru; A G Hovanessian
Journal:  EMBO J       Date:  1987-03       Impact factor: 11.598

View more
  14 in total

1.  Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine.

Authors:  Jeremy M Luke; Gregory G Simon; Jonas Söderholm; John S Errett; J Thomas August; Michael Gale; Clague P Hodgson; James A Williams
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

2.  Viral dsRNA inhibitors prevent self-association and autophosphorylation of PKR.

Authors:  Sean A McKenna; Darrin A Lindhout; Takashi Shimoike; Colin Echeverría Aitken; Joseph D Puglisi
Journal:  J Mol Biol       Date:  2007-06-15       Impact factor: 5.469

Review 3.  Structure, function, and evolution of adenovirus-associated RNA: a phylogenetic approach.

Authors:  Y Ma; M B Mathews
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  Domain interactions in adenovirus VAI RNA mediate high-affinity PKR binding.

Authors:  Katherine Launer-Felty; James L Cole
Journal:  J Mol Biol       Date:  2014-01-04       Impact factor: 5.469

5.  Parvovirus Expresses a Small Noncoding RNA That Plays an Essential Role in Virus Replication.

Authors:  Zekun Wang; Weiran Shen; Fang Cheng; Xuefeng Deng; John F Engelhardt; Ziying Yan; Jianming Qiu
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

6.  Magnesium-dependent interaction of PKR with adenovirus VAI.

Authors:  Katherine Launer-Felty; C Jason Wong; Ahmed M Wahid; Graeme L Conn; James L Cole
Journal:  J Mol Biol       Date:  2010-08-14       Impact factor: 5.469

7.  Roles of E4orf6 and VA I RNA in adenovirus-mediated stimulation of human parvovirus B19 DNA replication and structural gene expression.

Authors:  Kerstin Winter; Kristina von Kietzell; Regine Heilbronn; Tanja Pozzuto; Henry Fechner; Stefan Weger
Journal:  J Virol       Date:  2012-02-22       Impact factor: 5.103

8.  Adeno-associated viruses can induce phosphorylation of eIF2alpha via PKR activation, which can be overcome by helper adenovirus type 5 virus-associated RNA.

Authors:  Ramnath Nayak; David J Pintel
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

9.  The PKR-binding domain of adenovirus VA RNAI exists as a mixture of two functionally non-equivalent structures.

Authors:  Ahmed M Wahid; Veronica K Coventry; Graeme L Conn
Journal:  Nucleic Acids Res       Date:  2009-07-27       Impact factor: 16.971

10.  Analysis of adenovirus VA RNAI structure and stability using compensatory base pair modifications.

Authors:  Veronica K Coventry; Graeme L Conn
Journal:  Nucleic Acids Res       Date:  2008-02-03       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.